Derepression of c-Fos caused by MicroRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma

Cell Biochemistry and Function

Volumn 31, Issue 4, 2013, Pages 319-324

  Fan, Qin ^a   He, Minyi ^b   Deng, Xinjun ^b   Wu, William K K ^c   Zhao, Liang ^a   Tang, Jing ^a   Wen, Ge ^a   Sun, Xuegang ^a   Liu, Yawei ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C fos; Hepatocellular carcinoma; Metastasis; MicroRNA 139

Indexed keywords

LUCIFERASE; MICRORNA; MICRORNA 139; PROTEIN C FOS; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CELL MIGRATION; CONTROLLED STUDY; DEREPRESSION; DOWN REGULATION; EMBRYO; ENZYME REPRESSION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 84878728402     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2902     Document Type: Article

References (17)

1. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors and screening. Semin Liver Dis 2005; 25: 143-154.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
3. Tang ZY. Surgery of hepatocellular carcinoma with special reference to studies on metastasis and recurrence. Gastroenterol Today 2000; 4: 191-195.
4. Rana TM. Illuminating the silence: understanding the structure and function of small RNAS. Nat Rev Mol Cell Biol 2007; 8: 23-36.
5. Guo H, Ingolia TN, Weissman SJ, Bartel DP. Mammalian micrornas predominantly act to decrease target mRNA levels. Nature 2010; 466: 835-840.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. Microrna expression profiles classify human cancers. Nature 2005; 435: 834-838.
7. Wong CC, Wong CM, Tung EK, Au SL, Lee JM, et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 2011; 140: 322-331.
8. Tian J, Tang ZY, Ye S-L, et al. New human hepatocellular carcinoma (hcc) cell line with highly metastatic potential (MHCC97) and its expression of the factors associated with metastasis. Br J Cancer 1999; 81: 814-821.
9. Li Y, Tang ZY, Ye SL, Liu YK, Lin ZY, et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol 2001; 7: 630-636.
10. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3: 1101-1108.
11. Livak KJ, Schmittgen DT. Analysis of relative gene expression data using realtime quantitative PCR and the 2-ΔΔCt method. Methods 2001; 25: 402-408.
12. Ruan J, Liu F, Chen X, Zhao P, Su N, et al. Inhibition of glypican-3 expression via RNA interference influences the growth and invasive ability of the MHCC97-H human hepatocellular carcinoma cell line. Int J Mol Med 2011; 28: 497-503.
13. Ding SJ, Li Y, Shao XX, Zhou H, Zeng R, et al. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004; 4: 982-994.
14. Yoon JH, Choi YJ, Lee SG. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells. Eur J Pharmacol 2012; 679: 24-33.
15. Lee J, Lim KT. Preventive effect of phytoglycoprotein (38kDa) on expression of alpha-fetoprotein and matrix metalloproteinase-9 in diethylnitrosamine-treated ICR MICE. Drug Chem Toxicol 2011; Epub ahead of print.
16. Liu X, Xiong F, Wei X, Yang H, Zhou R. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells. Cancer Sci 2009; 100: 2335-2340.
17. Guo L, Guo Y, Xiao S. Expression of tyrosine kinase Etk/Bmx and its relationship with AP-1- and NF-kappaB-associated proteins in hepatocellular carcinoma. Oncology 2007; 72: 410-416.